Tiofacic; Tiase; Bronco-plus; Stepronine [INN-French]; Steproninum [INN-Latin]; Stepronino [INN-Spanish]; Stepronin [INN]; 2-[2-(thiophene-2-carbonylsulfanyl)propanoylamino]acetic acid; Prostenoglycine; Stepronin (INN); 72324-18-6 (free acid); (2-((thiophene-2-carbonyl)thio)propanoyl)glycine; Stepronine; Stepronino; Steproninum; C10H11NO4S2; EINECS 276-587-4; 2-(alpha-Thenoylthio)propionylglycine; masor; N-(2-(2-Thienylcarbonylthio)propionyl)glycin; N-(1-Oxo-2-((2-thienylcarbonyl)thio)propyl)glycine; SCHEMBL19338; MLS006010031; CHEMBL2107531; Glycine, N-(1-oxo-2-((2-thienylcarbonyl)thio)propyl)-; 2-(a-thenoylthio)propionylglycine; DTXSID00868127; N-(2-Mercaptopropionyl)glycine 2-thiophenecarboxylate (ester); BCP13544; BDBM50248155; KM1471; AKOS015900589; DB01423; VA11787; AC-15511; AS-13356; SMR004701210; DB-055627; FT-0630808; D07381; 324S186; A837481; N-{2-[(2-Thienylcarbonyl)sulfanyl]propanoyl}glycine; Q7611141; W-104492; 2-(2-(thiophene-2-carbonylthio)propanamido)acetic acid; 2-(2-thiophen-2-ylcarbonylsulfanylpropanoylamino)ethanoic acid; 2-{2-[(thiophen-2-yl)carbonylsulfanyl]propanamido}acetic acid; 2-[[1-oxo-2-[[oxo(thiophen-2-yl)methyl]thio]propyl]amino]acetic acid